Ignite Creation Date:
2024-05-06 @ 3:14 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02249221
Status:
COMPLETED
Last Update Posted:
2014-12-05
First Post:
2014-09-23
Brief Title:
Safety Tolerability and Immunogenicity of GC3106 Quadrivalent Cell-culture Based Influenza Vaccine
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-23
First Submit QC Date:
September 23 2014
Study First Post Date:
2014-09-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-04
Last Update Post Date:
2014-12-05
Last Update Post Date Type:
ESTIMATED